• OPEN AN ACCOUNT
Indian Indices
Sensex
73,123.83 -125.56
( -0.17%)
Global Indices
Nasdaq
52,230.09 -658.89
(-1.25%)
Dow Jones
7,644.13 -40.30
(-0.52%)
Hang Seng
62,584.98 -322.86
(-0.51%)
Nikkei 225
10,670.63 -54.40
(-0.51%)
Forex
USD-INR
94.61 0.10
(0.11%)
EUR-INR
106.18 0.08
(0.07%)
GBP-INR
126.70 0.19
(0.15%)
JPY-INR
0.60 0.00
(0.70%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
276.4035981
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
43.02
1037.7
EPS(TTM)
Face Value()
Div & Yield %
20.47
10
0.06
 

b2b software technologies ltd
DCM Shriram Industries receives revision in credit ratings from CARE
Apr 07,2026

DCM Shriram Industries has received review in credit ratings from CARE Ratings as under:

Long term bank facilities - CARE A-; Stable (Downgraded from CARE A+ and removed from Rating Watch with Negative implications; stable outlook assigned)

Short term bank facilities - CARE A2+ (Downgraded from CARE A1+ and removed from Rating Watch with Negative implications)

Fixed deposits - CARE A-; Stable (Downgraded from CARE A+ and removed from Rating Watch with Negative implications; stable outlook assigned)